# Spero Therapeutics, Inc.: Form 8-K, filed Sep 10, 2024

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: 8-K
- Filed: 2024-09-10
- Accepted by EDGAR: Sep 10, 2024, 06:56 ET
- Period: 2024-09-09
- Accession: 0001193125-24-216310
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312524216310/d819424d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312524216310/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312524216310/d819424d8k.htm

Filed Sep 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-216310. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.
